Literature DB >> 22082566

Serum amyloid A protects murine macrophages from lethal toxin-mediated death.

Kira Rose1, Paul Long, Malini Shankar, Jimmy D Ballard, Carol F Webb.   

Abstract

Lethal toxin, a key virulence factor produced by Bacillus anthracis, induces cell death, in part by disrupting numerous signaling pathways, in mouse macrophages. However, exposure to sublethal doses of lethal toxin allows some cells to survive. Because these pro-survival signaling events occur within a few hours after exposure to sublethal doses, we hypothesized that acute phase proteins might influence macrophage survival. Our data show that serum amyloid A (SAA) is produced in response to lethal toxin treatment. Moreover, pre-treatment of macrophages with exogenous SAA protected macrophages from lethal toxin-mediated death. Exogenous SAA activated the p38 mitogen activated protein kinase (MAP) kinase pathway, while lethal toxin mutants incapable of p38 activation were incapable of causing cell death. Chemical inhibition of the p38 activation pathway abrogated the protective effects of SAA. These data show that SAA affords protection against lethal toxin in mouse macrophages and link this response to the p38 pathway.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22082566      PMCID: PMC3244522          DOI: 10.1016/j.cellimm.2011.10.014

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  33 in total

Review 1.  Acute phase response in animals: a review.

Authors:  Carolyn Cray; Julia Zaias; Norman H Altman
Journal:  Comp Med       Date:  2009-12       Impact factor: 0.982

2.  Serum amyloid A is an activator of PMN antimicrobial functions: induction of degranulation, phagocytosis, and enhancement of anti-Candida activity.

Authors:  R Badolato; J M Wang; S L Stornello; A N Ponzi; M Duse; T Musso
Journal:  J Leukoc Biol       Date:  2000-03       Impact factor: 4.962

Review 3.  The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity.

Authors:  Fiorella Tonello; Cesare Montecucco
Journal:  Mol Aspects Med       Date:  2009-08-07

4.  Serum amyloid A secretion from monocytic leukaemia cell line THP-1 and cultured human peripheral monocytes.

Authors:  T Yamada; A Wada; K Itoh; J Igari
Journal:  Scand J Immunol       Date:  2000-07       Impact factor: 3.487

5.  Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition.

Authors:  Jin Mo Park; Florian R Greten; Zhi-Wei Li; Michael Karin
Journal:  Science       Date:  2002-08-29       Impact factor: 47.728

6.  Critical role of the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase-3 signaling pathway in recovery from anthrax lethal toxin-induced cell cycle arrest and MEK cleavage in macrophages.

Authors:  Soon-Duck Ha; Dennis Ng; Steven L Pelech; Sung Ouk Kim
Journal:  J Biol Chem       Date:  2007-10-19       Impact factor: 5.157

7.  Expression of interferon-beta during the triggering phase of macrophage cytocidal activation. Evidence for an autocrine/paracrine role in the regulation of this state.

Authors:  D W Riches; G A Underwood
Journal:  J Biol Chem       Date:  1991-12-25       Impact factor: 5.157

8.  Differential transcription of the mouse acute phase serum amyloid A genes in response to pro-inflammatory cytokines.

Authors:  Caroline F Thorn; Alexander S Whitehead
Journal:  Amyloid       Date:  2002-12       Impact factor: 7.141

Review 9.  Cellular and systemic effects of anthrax lethal toxin and edema toxin.

Authors:  Mahtab Moayeri; Stephen H Leppla
Journal:  Mol Aspects Med       Date:  2009-07-26

10.  Mitochondrial proteins Bnip3 and Bnip3L are involved in anthrax lethal toxin-induced macrophage cell death.

Authors:  Soon-Duck Ha; Dennis Ng; Julie Lamothe; Miguel A Valvano; Jiahuai Han; Sung Ouk Kim
Journal:  J Biol Chem       Date:  2007-07-10       Impact factor: 5.157

View more
  1 in total

Review 1.  The turning away of serum amyloid A biological activities and receptor usage.

Authors:  Sara Abouelasrar Salama; Mieke Gouwy; Jo Van Damme; Sofie Struyf
Journal:  Immunology       Date:  2021-01-04       Impact factor: 7.215

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.